Our management team has an extensive track record and experience in the research, development and delivery of RNA therapeutics, with over 50 years of combined experience in RNA delivery technologies and RNA therapeutics.

Robert W. Overell, Ph.D.

President and Chief Executive Officer

Read Bio

Michael Houston, Ph.D.

Chief Scientific Officer

Read Bio

Gordon Brandt, M.D.

Chief Medical Officer

Read Bio

Mary G. Prieve, Ph.D.

Vice President of Biology

Read Bio

Helen Tsui

Senior Vice President, Finance

Read Bio

Sean Monahan, Ph.D.

Vice President of Chemistry

Read Bio


James Watson, MBA

Head of Corporate Development

Read Bio